Originally published In Press as doi:10.1074/jbc.M106430200 on November 2, 2001
J. Biol. Chem., Vol. 277, Issue 2, 1354-1360, January 11, 2002
Regulation of Adenylyl Cyclases by a Region Outside the Minimally
Functional Cytoplasmic Domains*
Carole A.
Parent
,
Jane
Borleis§, and
Peter N.
Devreotes§
From the Department of Biological Chemistry, The Johns Hopkins
School of Medicine, Baltimore, Maryland 21205
Received for publication, July 9, 2001, and in revised form, September 24, 2001
 |
ABSTRACT |
The highly conserved topological structure of G
protein-activated adenylyl cyclases seems unnecessary because the
soluble cytoplasmic domains retain regulatory and catalytic properties. Yet, we previously isolated a constitutively active mutant of the
Dictyostelium discoideum adenylyl cyclase harboring a
single point mutation in the region linking the cytoplasmic and
membrane domains (Leu-394). We show here that multiple amino acid
substitutions at Leu-394 also display constitutive activity. The
constitutive activity of these mutants is not dependent on G proteins
or cytosolic regulators, although some of the mutants can be activated
to higher levels than wild type. Combining a constitutive mutation such as L394T with K482N, a point mutation that renders the enzyme insensitive to regulators, restores an enzyme with wild type properties of low basal activity and the capacity to be activated by G proteins. Thus regions located outside the cytoplasmic loops of adenylyl cyclases
are not only important in the acquisition of an activated conformation,
they also have impact on other regions within the catalytic core of the enzyme.
 |
INTRODUCTION |
G protein-coupled adenylyl cyclases are responsible for the
synthesis of the ubiquitous second messenger cAMP. In eukaryotic cells,
cAMP regulates a multitude of cellular responses, including cell growth
and differentiation, metabolism, and synaptic transmission (1, 2).
Modulation of adenylyl cyclase activity is thus responsible for a wide
variety of biological and pathological states. Hormones,
neurotransmitters, odorants, and chemokines control this activity by
interacting with G protein-coupled receptors. These activated receptors
stimulate the exchange of GDP for GTP on the
-subunit of the
heterotrimeric G proteins, and the
-subunit dissociates from the

complex. Both the activated G
-subunit and the released
G
complex can stimulate or inhibit adenylyl cyclase activity. In
mammalian cells, at least nine different forms of this enzyme have been
cloned, and each subtype has been shown to possess a specific pattern
of regulation and expression. Although these adenylyl cyclases are all
activated by Gs
, they show a distinct response to
Gi
- and G
-subunits, Ca2+,
Ca2+/calmodulin, as well as protein kinase A and C. In
Drosophila, a large family of these enzymes has also been
identified (3). One enzyme has been shown to be involved in learning
and memory (4). In the social amoebae Dictyostelium
discoideum, the expression of a single G protein-coupled adenylyl
cyclase, named ACA,1 is
essential for the survival of this lower eukaryote (5).
Adenylyl cyclases share a common topology predicted to consist of two
sets of six transmembrane helices and two large cytoplasmic domains (C1
and C2) located C-terminally to each set of helices (2). Each
cytoplasmic domain contains a region of homology (designated C1a and
C2a) with the cytoplasmic domains of several adenylyl and guanylyl
cyclases. The interaction between the two cytoplasmic domains of
adenylyl cyclases is necessary for the activation of the enzyme; the
catalytic and G protein-mediated activities are retained by separately
purifying and mixing the two cytoplasmic domains (6). The availability
of such a soluble form of adenylyl cyclases has allowed the completion
of crystallographic studies (7, 8). These studies revealed that the
C1/C2 catalytic core is a symmetric heterodimer that binds one molecule
of Gs
, one molecule of forskolin (a hypotensive drug
that stimulates all mammalian forms, except type IX), and one molecule
of ATP. The active site of the enzyme is located at the C1/C2
interface. It has been proposed that G proteins regulate the activity
of the enzyme by inducing a conformational change that reorients the C1
and C2 domains.
In D. discoideum, the proper regulation of the G
protein-coupled adenylyl cyclase ACA is essential for the early stages
of development during which starvation induces cells to aggregate and
differentiate into spores atop a stalk of vacuolated cells (9). In this
system, cAMP acts like a hormone; after its synthesis, it is secreted
and it binds to specific G protein-coupled receptors called cARs (cAMP
receptors). Receptor occupancy leads to the activation of several
effectors including ACA, and the signal is thereby relayed to
neighboring cells. Genetic analysis revealed that receptor-mediated
activation of ACA requires, in addition to heterotrimeric G proteins,
several cytoplasmic regulators. Among them, CRAC (cytosolic
regulator of adenylyl cyclase), a novel soluble protein containing a pleckstrin homology domain, is
recruited to the plasma membrane in response to receptor activation and
is absolutely required for receptor and GTP
S activation of ACA (10).
Consequently, crac
cells cannot activate ACA,
do not aggregate, and remain as smooth monolayers when starved (11). By
using random mutagenesis and phenotypic rescue of
crac
cells, we previously isolated a mutant of
ACA displaying constitutive activity that required neither receptor
activation nor cytoplasmic regulators (12). This mutant harbored a
single point mutation, Leu-394, located N-terminally to the
first cytoplasmic domain just after the first hydrophobic cluster. To
determine whether this domain is involved in the formation of an
activated conformation of ACA, we mutagenized the amino acid sequence
in that region and assessed the consequence of these alterations on the
developmental and biochemical phenotypes of D. discoideum
aca
and crac
cells
expressing the mutants.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines and Culture Conditions--
The
crac
, aca
, and
g
cell lines were generated previously by
homologous recombination and maintained in standard HL5 media (5, 11,
13). Transformants with wild type and mutant ACA plasmids were obtained
by electroporation (14), selected with 20 µg/ml G418, grown in
shaking suspension to densities of 2-5 × 106
cells/ml, and harvested for experimental analysis.
Oligonucleotide-directed Mutagenesis of ACA and Transformations
in D. discoideum Cells--
Site-directed mutagenesis was performed
using the MORPH Kit (5 Prime
3 Prime, Boulder, CO) with primers
encoding a specific codon or a partially degenerate primer at position
1180 of the ACA cDNA. A construct harboring a 7-amino acid deletion
(3 amino acids on either side of Leu-394 of ACA and Leu-394) was
generated using a primer missing the corresponding nucleotides and
containing 15 nucleotides 5' and 3' to the deleted domain to ensure
proper annealing. Finally, two plasmids with 3 Ala residues inserted 5'
or 3' of Leu-394 were also obtained using the MORPH Kit. For each of
these constructs, a plasmid containing an 800-bp fragment of ACA was
used as a template. The mutated ACA cDNA were subsequently cloned
into an extrachromosomal D. discoideum expression vector (pCP33), which gives high and constitutive expression. The resulting plasmids were electroporated into aca
and
crac
cells. Selected plasmids were also
transformed into g
cells.
Phenotypic Screening--
The transformed cells were grown in
shaking cultures to a density of 3-5 × 106 cells/ml,
harvested, washed once in DB (5 mM
Na2HPO4, 5 mM
NaH2PO4, pH 6.2, 2 mM
MgSO4, 200 µM CaCl2), resuspended
at 1 × 107 cells/ml, and plated on DB agar (15). The
plates were stored at 22 °C, and development was assessed 24 h
later. Under normal conditions, 1 × 107 cells were
plated on 35-mm plates. In some experiments, up to 1 × 108 cells were plated, and the resulting phenotype was
assessed 24 h later.
Immunoblotting--
Western analysis was performed as described
previously using a peptide antibody directed against the last 15 amino
acids of ACA (16). Detection was performed using enhanced chemiluminescence.
Adenylyl Cyclase Assays--
Enzyme activity was measured either
in vegetative cells, where the basal and unregulated
(MnSO4) activities of ACA can be assessed, or in cells
starved for 5 h (repeatedly stimulated with 75 nM
cAMP), where receptor and CRAC are expressed and the GTP
S activation
of ACA can be measured. Assays for adenylyl cyclase activation were
performed for 2 min at room temperature in the presence of 2 mM MgSO4 (basal), 5 mM
MnSO4, or 40 µM GTP
S and 1 µM cAMP as described previously (17). For the
receptor-mediated activation, the cells were stimulated with 10 µM cAMP, rapidly lysed at specific time points, and
assayed for 1 min at room temperature. Assays on membrane preparations
were performed as described previously (12).
 |
RESULTS |
By using site-directed mutagenesis, we replaced Leu-394 with 11 amino acids: 5 non-polar (Ala, Phe, Gly, Ile, and Pro); 3 polar (Asn,
Thr, and Tyr); 2 acidic (Asp and Glu); and 1 basic (Arg). These
constructs were cloned into an episomal plasmid, downstream of the
actin-15 promoter that gives high constitutive levels of expression,
and transformed in both aca
and
crac
cells. The developmental phenotype of
these cell lines on non-nutrient agar is shown in Fig.
1A. All substitutions at
Leu-394 gave rise to ACA molecules that could complement the
aca
cells, and many of the mutants suppressed
the aggregation-deficient phenotype of the
crac
cells. In addition to the original L394S
mutation, L394A, L394I, L394G, L394R, and L394T could all aggregate in
the absence of the essential cytoplasmic regulator CRAC. One mutant,
L394N, differentiated into weak aggregates and was thus scored as a
partial suppressor. Western analysis revealed that each mutant
expressed similar levels of ACA in both cell lines, although L394P
expressed significantly lower levels of protein and was not further
analyzed (Fig. 1B). Taken together, these observations
suggested that many of the substitutions rendered the enzyme
constitutively active.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Developmental phenotypes of
Leu-394-substituted ACA mutants. A, top
panel depicts representative developmental phenotypes observed
when the ACA mutants, L394A and L394Y, were expressed in
crac cells. The table reports the
phenotypes for each substitution mutant when expressed in
aca or crac cells.
The + and signs refer to the capability of the mutants to
suppress the aggregation-deficient phenotypes of the parent cell line.
The N/crac cells partially rescued the
development and showed only loose aggregates after starvation.
Transformants were grown in liquid culture and washed, and 1 × 107 cells were plated on 35-mm plates at 22 °C on
non-nutrient agar. Photographs were taken 24 h after the cells
were plated. Bar represents 2 mm. B, ACA protein
expression of the substituted mutants in crac
cells. Western analysis was performed using a peptide antibody directed
against the last 15 amino acids of ACA. Detection was performed using
enhanced chemiluminescence. L represents the wild type
sequence of ACA. Identical results were observed when the mutants were
expressed in aca cells.
|
|
We next evaluated the intrinsic adenylyl cyclase activity of each
mutant by measuring the enzyme activity in the presence of
Mn2+ (Fig. 2A).
Mn2+, a more potent cofactor than Mg2+, will
stimulate the enzymatic activity in the absence of G proteins (18). It
is thus used to assess the integrity of the catalytic core. As
expected, all mutants expressed in either aca
or crac
cells showed high enzyme activities in
the presence of Mn2+ (results are shown for the mutants
expressed in crac
cells only). However, their
activities, measured in the presence of Mg2+, varied
greatly. For a number of mutants, the activity in the absence of
Mn2+ was close to their activity in the presence of
Mn2+ (Fig. 2B). By comparing the
Mg2+/Mn2+ adenylyl cyclase activity ratio of
the mutants with their developmental phenotype, we observed that a
certain level of adenylyl cyclase activity suppressed the
aggregation-deficient phenotype of the crac
cells. A substitution leading to a ratio of 0.5 or greater
(corresponding to an activity of ~50 pmol/min/mg) was sufficient. The
glycine mutant defined the boundary between the two classes of mutants. These data show that single point mutations on adenylyl cyclases give
rise to enzymes possessing distinct intrinsic activities.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Adenylyl cyclase activation of
Leu-394-substituted ACA mutants expressed in
crac cells. A, basal and
MnSO4-stimulated adenylyl cyclase activity. Mutant cell
lines were grown, washed, lysed, and assayed for 2 min with and without
5 mM MnSO4 as described under "Experimental
Procedures." The results presented were performed in duplicate and
are representative of at least three independent experiments.
B, cumulative adenylyl cyclase activation expressed as a
ratio of Basal/MnSO4 activity. The values presented are the
mean ± S.E. of three to eight independent experiments.
L represents the wild type sequence of ACA.
|
|
The original mutant, L394S, rescued the aggregation-deficient phenotype
of crac
cells by providing a constant high
source of cAMP (12). It displayed no significant activation in response
to either receptor or GTP
S stimulation in
crac
cells, and the same high basal activity
was observed in membranes derived from
L394S/g
cells, confirming that the mutant
was not supersensitive to G proteins or cytosolic regulators. The new
mutants showed a similar behavior. As expected, when expressed in
crac
cells, none showed a response to GTP
S
(data not shown). Next, we transformed three representative mutants in
g
cells and measured the adenylyl cyclase
activity in both lysates and membrane preparations. The three mutants
retained high basal activity in the absence of functional G proteins
(Fig. 3). Moreover, the high activity was
measured in both cell lysates and membrane preparations. Interestingly,
for both control and mutant enzymes, the
Mg2+/Mn2+ activity ratio was further elevated
in membrane preparations compared with cell lysates (Fig. 3). We also
observed that many of the constitutively active mutants possessed a
residual activation potential because they could be further activated
when expressed in aca
cells. In this parental
background, where wild type levels of G proteins and CRAC are
expressed, the mutants showed a 2-3-fold stimulation in response to
GTP
S (Fig. 4). This behavior was also observed with the original L394S mutant. Intriguingly, L394I showed the
weakest stimulation in the presence of GTP
S (Fig. 4).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Adenylyl cyclase activity of Leu-394
substituted ACA mutants expressed in
g cells. Basal and
MnSO4-stimulated adenylyl cyclase activities were measured
in lysates and membrane preparations with and without MnSO4
as described under "Experimental Procedures." The results,
performed in duplicates, are expressed as a ratio of
Basal/MnSO4 adenylyl cyclase activity and are
representative of at least two independent experiments.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
GTP S-stimulated
adenylyl cyclase activity in aca cell
lines expressing Leu-394-substituted ACA mutants. Cells were
starved for 5 h and assayed for 2 min at room temperature in the
presence of 2 mM MgSO4 (basal) or 40 µM GTP S plus 1 µM cAMP (see
"Experimental Procedures"). The results, performed in duplicate,
are expressed as a ratio of the adenylyl cyclase
activity/MnSO4 activity and are representative of at least
two independent experiments.
|
|
We next wanted to more generally disturb the N-terminal domain of the
C1 loop of ACA. We generated three mutants that harbored the following
alteration in the ACA protein: two mutants were designed to have three
alanine insertions either N-terminal (AAAL) or C-terminal (LAAA) from
the Leu-394 residue, and one had a 7-amino acid deletion (Del) across
the Leu-394 residue, three residues on either side of the leucine along
with the Leu-394 residue. Each construct was transformed in both
aca
and crac
cells.
Fig. 5A shows that each mutant
expressed the mutated ACA protein in both cell lines, although the
mutants regularly showed lower expression compared with their wild type
counterpart. Phenotypic analysis revealed that none of these
substitutions suppressed the aggregation-deficient phenotype of the
crac
cells, suggesting that they did not
display constitutive activity (Fig. 5A). When expressed in
the aca
background, we observed that the Del
mutant acquired a severely impaired conformation. Indeed, although both
the AAAL and LAAA mutants could complement the
aca
cells, the
Del/aca
cell lines remained
aggregation-deficient when plated on non-nutrient agar (Fig.
5A). These results suggest that this mutation has a deleterious effect on G protein-mediated activation of ACA. Indeed, as
shown in Fig. 5B, the Del/aca
showed only a weak response to GTP
S. It thus appears that the N-terminal domain of the C1 loop of adenylyl cyclases is critical for
the acquisition of an activated conformation.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Adenylyl cyclase activity of wild type,
alanine insertional, and deletion ACA mutants. A, ACA
protein expression and developmental phenotypes of the mutants when
expressed in aca and
crac cells. B, adenylyl cyclase
activity was performed as described in legend of Fig. 4. The results,
performed in duplicates, are expressed as a ratio of the adenylyl
cyclase activity/MnSO4 activity and are representative of
at least five independent experiments. L represents the wild
type sequence of ACA. LAAA and AAAL designate 3' and 5' of Leu-394
alanine insertions. Del indicates a mutant of ACA carrying a
7-amino acid deletion spanning the Leu-394 residue.
|
|
To address this point further, we designed an enzyme that contained, in
addition to a constitutive mutation, a substitution that rendered the
enzyme insensitive to G protein activation. In a previous screen
designed to isolate loss-of-function mutants of ACA, we identified
several mutants that remained aggregation-deficient when expressed in
aca
cells. These mutants displayed normal
Mg2+/Mn2+ adenylyl cyclase activity ratios but
showed no response to GTP
S stimulation and were unable to enter
development when plated on non-nutrient agar (16). One of these
uncoupled mutants harbored a single point mutation (K482N) in the C1
loop of ACA. We introduced the L394T substitution, the strongest
constitutive mutant, in the K482N background to construct the double
mutant. The double mutant was electroporated in
aca
cells, and the developmental phenotype of
the resulting transformants was assessed. Western analysis revealed
that the L394T,K482N/aca
, and the
Leu-394/aca
cells expressed similar levels of
ACA (data not shown). Under normal plating conditions, the mutant cells
did not rescue the aggregation-deficient phenotype of the
aca
cells. However, when plated at higher
density, the L394T,K482N/aca
cells did enter
development to form small mounds and fruiting bodies, a result never
observed with aca
or
K482N/aca
cells (Fig.
6A). The presence of K482N
altered the basal activity of the L394T mutation. Under our standard
measurement conditions, L394T,K482N displayed a
Mg2+/Mn2+ adenylyl cyclase activity ratio of
0.3 compared with > 0.7 for the L394T mutant. On the other hand,
L394T,K482N exhibited a significant activation in the presence of
GTP
S (Fig. 6B). This activation, which was never observed
in K482N/aca
cells, was also detected when the
adenylyl cyclase activity was measured in vivo after
receptor stimulation (Fig. 6C).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
Developmental and biochemical phenotype of
L394T,K482N/aca cells.
A, aca and
L394T,K482N/aca cells were grown in liquid
culture and washed, and 1 × 108 cells were plated on
non-nutrient agar on 35-mm plates at 22 °C. Photographs were taken
24 h after the cells were plated. B, basal,
MnSO4, and GTP S-stimulated adenylyl cyclase activity in
L/aca , K482N/aca , and
L394T,K482N/aca cells. The assays were
performed as described under "Experimental Procedures." The results
were performed in duplicate and are representative of at least three
independent experiments. C, receptor-mediated activation of
adenylyl cyclase in L/aca ,
K482N/aca , and
L394T,K482N/aca cells. Cells were stimulated
with 10 µM cAMP, rapidly lysed at specific time points,
and assayed as described under "Experimental Procedures." The
results were performed in duplicate and are representative of at least
two independent experiments.
|
|
 |
DISCUSSION |
Throughout evolution, the topology of G protein-coupled adenylyl
cyclases has been remarkably conserved. D. discoideum,
Drosophila, and mammals all express enzymes that are
predicted to display two sets of 6 transmembrane domains followed by a
large cytoplasmic loop (Fig. 7). Although
it has been proposed that some adenylyl cyclases are responsive to
transmembrane potential, the exact function of the transmembrane spans
has remained largely unknown (19). Our data show that regions linking
the transmembrane domains to the cytoplasmic loops are important for
proper regulation of the enzyme. The crystal structure of the soluble
adenylyl cyclase with Gs
revealed that the
-subunit
of G proteins binds to a crevice on the outside of the C2 loop on
residues mainly located on the
2 helix, as well as to residues on
the N-terminal portion of the C1 loop (8). The Leu-394 residue of ACA
that is mutated in this study is located ~35 amino acids upstream of
this N-terminal portion of the C1 loop (Fig. 7). In fact, important
biochemical differences between the soluble and native forms of
adenylyl cyclases have been observed. First, the affinity of the
soluble adenylyl cyclase for Gs
is significantly
reduced, ~50-fold, compared with the native enzyme (20, 21). Second,
the effects of G
-subunits on the chimeric soluble preparations do
not recapitulate what has been observed with the purified full-length
enzymes (22, 23). Finally, the maximal stimulated activity is
~10-fold higher for the soluble enzyme (21, 22). Moreover, the F400Y
mutation in the type V molecule, which showed increased basal activity and sensitivity to Gs
and forskolin, did not alter the
enzymatic activity of the soluble construct bearing the same
substitution (24, 25). It has been shown that the C1b domain of
adenylyl cyclases (which is absent in these constructs) possesses
regulatory properties (26-31). Particularly, the type VI enzyme has a
cAMP-dependent protein kinase phosphorylation site within
its C1b region that dampens Gs
-mediated activation (32).
In addition, glycosylation of the extracellular domains of the type VI
enzyme has recently been shown to be important for catalytic activity
(33). It is thus possible that some of the differences observed between
the native and soluble forms of adenylyl cyclases could be explained by
the lack of these domains in the soluble constructs. Our data support
and extend these observations by defining yet another region of the
native structure that is critical for activation.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 7.
Sequence analysis of the location of
the ACA mutants. The C1 and C2 domains of D. discoideum
ACA and the mammalian type II adenylyl cyclases were aligned using
ClustalW analysis. The amino acid position of the sequences is shown at
the end of each line. The secondary structure of the C1 loop
(8) is drawn below the consensus sequence in
blue. The Leu-394 and Lys-482 residues are shown in
red and blue, respectively. The L405S and F421S
mutations are shown in green. The putative native structure
of adenylyl cyclases is illustrated in the bottom left
corner. The boxed region represents the sequence
contained within the soluble construct.
|
|
Hatley et al. (25) isolated mutants of the type II enzyme
that rescued the cyclase-null Saccharomyces cerevisiae
strain. All mutations mapped to the cytoplasmic loops of the enzyme. To investigate the biochemical defect of the mutants, the substitutions were engineered in the type V C1/type II C2 soluble construct. Of 13 mutants analyzed in this context, only a few displayed substantial changes in adenylyl cyclase activity when compared with the wild type
control. Because the activity of the mutants was not measured in the
context of the native type II enzyme, the lack of change in basal
activity in most of the mutants analyzed may be due to the absence of
the transmembrane domains or, alternatively, to the supersensitivity of
the yeast screen.
We have shown that the activity of native adenylyl cyclases can be
dramatically modulated by substituting Leu-394 of ACA. This residue is
conserved in eight of nine of the mammalian adenylyl cyclases (Fig. 7)
(12). Substituting Leu-394 of ACA with a variety of other residues
gives rise to mutants possessing high basal activity. Intriguingly, the
substitutions lead to graded ranges of high basal activity suggesting
that each mutant acquires a conformation that progressively reproduces
the active state of the enzyme and that the Leu-394 position is
critical in the formation of an activated conformation of adenylyl
cyclases. This type of graded effect has also been observed when the
Ala-293 position of the
1B-adrenergic receptor is
mutated to other amino acids (34). A closer analysis of the nature of
the amino acids leading to the broad spectrum of intrinsic adenylyl
cyclase activation reveals no particular allegiance regarding charge,
size, or hydrophobicity. Surprisingly, the subtlest mutation (L394I)
provides significant constitutive activity. It thus seems that changes
in the local conformation is responsible for the acquired high
activity. Consequently, we do not expect that substitutions of this
particular residue in other adenylyl cyclases will lead to
constitutively active enzymes. Indeed, the mammalian type V enzyme
harbors a serine at the corresponding Leu-394 position and does not
display unusually high basal activity. We propose that changes in the N
terminus region of the C1 loop will lead to enzymes that display high
basal activity. A screen similar to the one we developed for ACA will be required to identify such mutations in mammalian enzymes (12).
Mutations localized to the N terminus of the C1 loop of ACA also give
rise to enzymes that are non-responsive to G proteins. In a previous
study, we isolated a mutant that harbored two point mutations (L405S
and F421S) adjacent to the Leu-394 position (Fig. 7). This mutant
showed normal enzymatic activity in the presence of MnSO4.
However, it was devoid of any G protein-mediated activation (16). This
behavior is identical to the one observed with the Del mutant
engineered in the present study. Interestingly, the AAAL mutant had the
opposite phenotype displaying increased G protein-mediated activation
compared with the wild type enzyme. Taken together, these mutants,
which all harbor mutations in a discrete region outside the soluble
domains, underscore the importance of this region on the activation
potential of adenylyl cyclases.
Structural information shows that the C1/C2 heterodimer structure is
based on highly organized interactions between the two domains. It has
been suggested that extensive hydrogen bonding between the
4-
5
loops of C2 and the
2-
3 loops of C1 exist and that alterations in
these interactions have deleterious effects on enzymatic activity (8).
The ACA K482N mutant, which is specifically devoid of G
protein-stimulated activity, harbors a point mutation in the highly
conserved
2 loop of C1 (Fig. 7). Mutations of this exact residue in
mammalian adenylyl cyclases also give rise to defective enzymes (35,
36). The addition of the constitutive mutation L394T to the K482N
substitution biochemically and phenotypically suppresses the defects of
the K482N mutant. The L394T,K482N/aca
cells
regain the capacity to aggregate, respond to GTP
S, and show a
significant response to receptor stimulation. As with the original
K482N/aca
mutant, these results again show
that the Lys-482 residue is not essential for the catalytic activation
of adenylyl cyclases. The fact that the constitutive mutation can
suppress the loss-of-function defect shows that the two sites, although
distant, influence each other. Intriguingly, whereas the double mutant
regains the capacity to be activated by G proteins, it does not exhibit
the constitutive activity of the L394T mutant. It thus appears that the
high basal activity of the L394T mutant is somehow lost in the context
of the double mutant. Although additional experiments are required to
understand the molecular mechanism explaining this interesting behavior, the results presented in this paper definitely show that a
region located outside the soluble construct of adenylyl cyclases is
pivotal in the acquisition of an activated conformation.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Robert Insall and Lijun Wu for
providing the crac
and
g
cell lines. We also wish to thank Drs.
Pierre Coulombe and Frank Comer and Paul Kriebel for reading the manuscript.
 |
FOOTNOTES |
*
This work was supported by American Cancer Society Grant
DB-1c (to P. N. D.) and National Institutes of Health Grant GM57874 (to C. A. P. and P. N. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of Cellular
and Molecular Biology, NCI, National Institutes of Health, 37 Convent Dr., Bldg. 37, Rm. 1E24, Bethesda, MD 20892-4255. Tel.: 301-435-3701; Fax: 301-496-8479; E-mail: parentc@helix.nih.gov.
§
Present address: Dept. of Cell Biology and Anatomy, The Johns
Hopkins School of Medicine, 725 North Wolfe St., Baltimore MD 21205.
Published, JBC Papers in Press, November 2, 2001, DOI 10.1074/jbc.M106430200
 |
ABBREVIATIONS |
The abbreviations used are:
ACA, adenylyl
cyclase expressed during aggregation;
CRAC, cytosolic regulator of
adenylyl cyclase;
GTP
S, guanosine
5'-3-O-(thio)triphosphate.
 |
REFERENCES |
| 1.
|
Sunahara, R. K.,
Dessauer, C. W.,
and Gilman, A. G.
(1996)
Annu. Rev. Pharmacol. Toxicol.
36,
461-480
|
| 2.
|
Simonds, W. F.
(1999)
Trends Pharmacol. Sci.
20,
66-73
|
| 3.
|
Cann, M. J.,
and Levin, L. R.
(1998)
Adv. Second Messenger Phosphoprotein Res.
32,
121-135
|
| 4.
|
Levin, L. R.,
Han, P. L.,
Hwang, P. M.,
Feinstein, P. G.,
Davis, R. L.,
and Reed, R. R.
(1992)
Cell
68,
479-489
|
| 5.
|
Pitt, G. S.,
Milona, N.,
Borleis, J. A.,
Lin, K. C.,
Reed, R. R.,
and Devreotes, P. N.
(1992)
Cell
69,
305-315
|
| 6.
|
Tang, W. J.,
and Gilman, A. G.
(1995)
Science
268,
1769-1772
|
| 7.
|
Zhang, G.,
Liu, Y.,
Ruoha, A. E.,
and Hurley, J. H.
(1997)
Nature
386,
247-253
|
| 8.
|
Tesmer, J. J. G.,
Sunahara, R. K.,
Gilman, A. G.,
and Sprang, S. R.
(1997)
Science
278,
1907-1916
|
| 9.
|
Parent, C. A.,
and Devreotes, P. N.
(1996)
Annu. Rev. Biochem.
65,
411-440
|
| 10.
|
Lilly, P. J.,
and Devreotes, P. N.
(1995)
J. Cell Biol.
129,
1659-1665
|
| 11.
|
Insall, R.,
Kuspa, A.,
Lilly, P. J.,
Shaulsky, G.,
Levin, L. R.,
Loomis, W. F.,
and Devreotes, P. N.
(1994)
J. Cell Biol.
126,
1537-1545
|
| 12.
|
Parent, C. A.,
and Devreotes, P. N.
(1996)
J. Biol. Chem.
271,
18333-18336
|
| 13.
|
Lilly, P., Wu, L.,
Welker, D. L.,
and Devreotes, P. N.
(1993)
Genes Dev.
7,
986-995
|
| 14.
|
Howard, P. K.,
Ahern, K. G.,
and Firtel, R. A.
(1988)
Nucleic Acids Res.
16,
2613-2623
|
| 15.
|
Devreotes, P.,
Fontana, D.,
Klein, P.,
Sherring, J.,
and Theibert, A.
(1987)
Methods Cell Biol.
28,
299-331
|
| 16.
|
Parent, C. A.,
and Deveotes, P. N.
(1995)
J. Biol. Chem.
270,
22693-22696
|
| 17.
|
Pupillo, M.,
Insall, R. H.,
Pitt, G. S.,
and Devreotes, P. N.
(1992)
Mol. Biol. Cell
3,
1229-1234
|
| 18.
|
Tesmer, J. J. G.,
and Sprang, S. R.
(1998)
Curr. Opin. Struct. Biol.
8,
713-719
|
| 19.
|
Reddy, R.,
Smith, D.,
Wayman, G., Wu, Z.,
Villacres, E. C.,
and Storm, D. R.
(1995)
J. Biol. Chem.
270,
14340-14346
|
| 20.
|
Tang, W. J.,
Krupinski, J.,
and Gilman, A. G.
(1991)
J. Biol. Chem.
266,
8595-8603
|
| 21.
|
Sunahara, R. K.,
Dessauer, C. W.,
Whisnant, R. E.,
Kleuss, C.,
and Gilman, A. G.
(1997)
J. Biol. Chem.
272,
22265-22271
|
| 22.
|
Taussig, R.,
Quarmby, L. M.,
and Gilman, A. G.
(1993)
J. Biol. Chem.
268,
9-12
|
| 23.
|
Dessauer, C. W.,
and Gilman, A. G.
(1996)
J. Biol. Chem.
271,
16967-16974
|
| 24.
|
Zimmermann, G.,
Zhou, D.,
and Taussig, R.
(1999)
Mol. Pharmacol.
56,
895-901
|
| 25.
|
Hatley, M. E.,
Benton, B. K., Xu, J.,
Manfredi, J. P.,
Gilman, A. G.,
and Sunahara, R. K.
(2000)
J. Biol. Chem.
275,
38626-38632
|
| 26.
|
Dessauer, C. W.,
Tesmer, J. J. G.,
Sprang, S. R.,
and Gilman, A. G.
(1998)
J. Biol. Chem.
273,
25831-25839
|
| 27.
|
Scholich, K.,
Barbier, A. J.,
Mullenix, J. B.,
and Patel, T. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2915-2920
|
| 28.
|
Scholich, K.,
Wittpoth, C.,
Barbier, A. J.,
Mullenix, J. B.,
and Patel, T. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9602-9607
|
| 29.
|
Tan, C. M.,
Kelvin, D. J.,
Litchfield, D. W.,
Ferguson, S. S. G.,
and Feldman, R. D.
(2001)
Biochemistry
40,
1702-1709
|
| 30.
|
Wittpoth, C.,
Scholich, K.,
Yigzaw, Y.,
Stringfield, T. M.,
and Patel, T. B.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9551-9556
|
| 31.
|
Yan, S.,
Beeler, J.,
Chen, Y.,
Shelton, R.,
and Tang, W.
(2001)
J. Biol. Chem.
276,
8500-8506
|
| 32.
|
Chen, Y.,
Harry, A., Li, J.,
Smit, M. J.,
Bai, X.,
Magnusson, R.,
Pieroni, J. P.,
Weng, G.,
and Iyengar, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14100-14104
|
| 33.
|
Wu, G. C.,
Lai, H. L.,
Lin, Y. W.,
Chu, Y. T.,
and Chern, Y.
(2001)
J. Biol. Chem.
276,
35450-35457
|
| 34.
|
Kjelsberg, M. A.,
Cotecchia, S.,
Ostrowski, J.,
Caron, M. G.,
and Lefkowitz, R. J.
(1992)
J. Biol. Chem.
267,
1430-1433
|
| 35.
|
Tang, W. J.,
Stanzel, M.,
and Gilman, A. G.
(1995)
Biochemistry
34,
14563-14572
|
| 36.
|
Zimmermann, G.,
Zhou, D.,
and Taussig, R.
(1998)
J. Biol. Chem.
273,
19650-19655
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Yoo, R. Iyengar, and Y. Chen
Functional Analysis of the Interface Regions Involved in Interactions between the Central Cytoplasmic Loop and the C-terminal Tail of Adenylyl Cyclase
J. Biol. Chem.,
April 2, 2004;
279(14):
13925 - 13933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-H. Lin, H.-L. Lai, Y.-Y. Kao, C.-N. Sun, M.-J. Hwang, and Y. Chern
Protein Kinase C Inhibits Type VI Adenylyl Cyclase by Phosphorylating the Regulatory N Domain and Two Catalytic C1 and C2 Domains
J. Biol. Chem.,
May 3, 2002;
277(18):
15721 - 15728.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.